Thyroid hormone levels improve the prediction of mortality among patients admitted to the intensive care unit

Intensive Care Medicine

Volumn 31, Issue 10, 2005, Pages 1356-1361

  Chinga Alayo, Erick ^a   Villena, Jaime ^b   Evans, Arthur T ^a   Zimic, Mirko ^b  

^a Jr Hospital of Cook County   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Acute Physiology and Chronic Health Evaluation; ICU survivors; Mortality prediction; Thyroid hormone; Thyroid stimulating hormone; Triiodothyronine

Indexed keywords

GROWTH HORMONE; HYDROCORTISONE; LIOTHYRONINE; PRASTERONE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FREE THYROXINE INDEX; GROWTH HORMONE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTENSIVE CARE; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

APACHE; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE; SURVIVAL ANALYSIS; THYROID HORMONES;

EID: 26644455698     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-005-2719-9     Document Type: Article

References (39)

1. Civetta JM (1997) Prediction and definition of outcome. In: Civetta JM, Taylor RW, Kirby RR (ed) Critical care. Lippincott-Raven, Philadelphia, pp 127-147
2. Jarek MJ, Legare EJ, McDermott MT, JA, Kollef MH (1993) Endocrine profiles for outcome prediction from the intensive care unit. Crit Care Med 21:543-550
3. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1986) An evaluation of outcome from intensive care in major medical center. Ann Intern Med 104:410-418
4. Schafer JH, Maurer A, Jochimsen F, Emde C, Wegscheider K, Arntz HR, Heitz J, Krell-Schroeder B, Distler A (1990) Outcome prediction models on admission in a medical intensive unit: do they predict individual outcome? Crit Care Med 18:1111-1117
5. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-829
6. Rothwell PM, Lawler PG (1995) Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 23:78-83
7. Rolih CA, Ober KP (1995) The endocrine response to critical illness. Med Clin North Am 79:211-224
8. Sumita S, Ujike Y, Namiki A, Watanabe H, Kawamata M, Watanabe A, Satoh O (1994) Suppression of the thyrotropin response to thyrotropin-releasing hormone and its association with severity of critical illness. Crit Care Med 22:1603-1609
9. Finlay WEI, McKee JI (1982) Serum Cortisol levels in severely stressed patients. Lancet I:1414-1415
10. Rothwell PM, Udwadia ZF, Lawler PG (1993) Thyrotropin concentration predicts outcome in critical illness. Anaesthesia 48:373-376
11. Kaptein EM, Weiner JM, Robinson WJ, Wheeler WS, Nicoloff JT (1982) Relationship of altered thyroid hormone indices to survival in nonthyroidal illness. Clin Endocrinol (Oxf) 16:565
12. Slag MF, Morley JE, Elson MK, Crowson TW, Nuttall FQ, Shafer RB (1981) Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 245:43-45
13. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341:785-792
14. Meikle AW, Daynes RA, Araneo, BA (1991) Adrenal androgen secretion and biological effects. Endocrinol Metab Clin North Am 20:381-400
15. Blauer KL, Poth M, Rogers WM, Bernton EW (1991) Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129:3174-3179
16. Suzuki T, Suzuki N, Daynes RA, Engleman EG (1991) Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T-cells. Clin Immunol Immunopathol 61:202-211
17. Dahn MS, Mitchell RA, Smith S, Lange MP, Whitcomb MP, Kirkpatrick JR (1984) Altered immunological function and nitrogen metabolism associated with depression of plasma growth hormone. JPEN J Parenter Enteral Nutr 8:690-694
18. Dorshkind K, Horseman ND (2001) Anterior pituitary hormones, stress, and immune system homeostasis. Bioessays 23:288-294
19. Russell DH (1989) New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation. Trends Pharmacol Sci 10:40-44
20. Noel GL, Suh HK, Stone JG, Frantz AG (1972) Human prolactin and growth hormone release during surgery and other conditions of stress. J Clin Endocrinol Metab 35:840-851
21. Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley-Interscience, New York
22. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36
23. McNeil BJ, Hanley JA (1984) Statistical approach to the analysis of receiver operating characteristic (ROC) curve. Med Decis Making 4:137-139
24. De Groot LJ (1999) Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 84:151-164
25. Chernow B, Anderson DM (1985) Endocrine responses to critical illness. Semin Respir Med 7:1-10
26. Van den Berghe G (2001) The neuroendocrine response to stress is a dynamic process. Baillieres Best Pract Res Clin Endocrinol Metab 15:405-419
27. Mechanick JI, Sacks HS, Cobin RH (1997) Hypothalamic-pituitary axis dysfunction in critically ill patients with a low free thyroxine index. J Endocrinol Invest 20:462-470
28. Leon-Sanz M, Lorente JA, Larrodera L, Ros P, Alvarez J, Esteban AE, Landin L (1997) Pituitary-thyroid function in patients with septic shock and its relation with outcome. Eur J Med Res 2:477-482
29. Ray DC, Macduff A, Drummond GB, Wilkinson E, Adams B, Beckett GJ (2002) Endocrine measurements in survivors and non-survivors from critical illness. Intensive Care Med 28:1301-1308
30. Ray DC, Drummond GB, Wilkinson E, Beckett GJ (1995) Relationship of admission thyroid function tests to outcome in critical illness. Anaesthesia 50:1022-1025
31. Vos RA, De Jong M, Bernard BF, Docter R, Krenning EP, Hennemann G (1995) Impaired thyroxine and 3,5,3′-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness. J Clin Endocrinol Metab 80:2364-2370
32. Wolf M, Hansen N, Greten H (1994) Interleukin 1 beta, tumor necrosis factor-alpha and interleukin 6 decrease nuclear thyroid hormone receptor capacity in a liver cell line. Eur J Endocrinol 131:307-312
33. Wartofsky L, Burman KD (1982) Alterations in thyroid function in patients with systemic illness: "the euthyroid sick syndrome." Endocr Rev 3:164-217
34. Chopra IJ, Teco GN, Nguyen AH, Solomon DH (1979) In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroidal illnesses. J Clin Endocrinol Metab 49:63-69
35. Chopra IJ, Solomon DH, Teco GN, Eisenberg JB (1982) An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues. Science 215:407-409
36. Span LF, Hermus AR, Bartelink AK, Hoitsma AJ, Gimbrere JS, Smals AG, Kloppenborg PW (1992) Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients. Intensive Care Med 18:93-96
37. Oppert M, Reinicke A, Graf KJ, Barckow D, Frei U, Eckardt KU (2000) Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med 26:1747-1755
38. Vermes I, Beishuizen A, Hampsink RM, Haanen C (1995) Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 80:1238-1242
39. Beishuizen A, Thijs LG, Vermes I (2001) Patterns of corticosteroid- binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 27:1584-1591